Lexeo Therapeutics, Inc. Common Stock
LXEO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $175,166 | $114,906 | $217,641 |
| - Cash | $40,996 | $35,480 | $28,913 | $35,014 |
| + Debt | $5,742 | $8,913 | $9,399 | $9,924 |
| Enterprise Value | – | $148,599 | $95,392 | $192,551 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$530 | -$510 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$19,731 | -$25,534 | -$32,115 | -$25,373 |
| % Margin | – | – | – | – |
| Net Income | -$20,283 | -$26,103 | -$32,656 | -$25,924 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.33 | -0.6 | -0.99 | -0.78 |
| % Growth | 45% | 39.4% | -26.9% | – |
| Operating Cash Flow | -$29,547 | -$27,219 | -$21,716 | -$28,326 |
| Capital Expenditures | -$289 | -$108 | $0 | $13 |
| Free Cash Flow | -$29,836 | -$27,327 | -$21,716 | -$28,313 |